Výsledky vyhledávání

Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology

Autor: Forough Farrokhyar, Bobby Shayegan, Kaitlyn F. Whelan, Jehonathan H. Pinthus, Magdy M. Hassouna, E. Woods, Orovan Wl

Publikováno v: BJU International. 110:1142-1148

What's known on the subject? and What does the study add? The experience with HIFU as a minimally invasive treatment for localized prostate cancer is relatively new and most reports are from European centres. Our study is unique in five regards: 1. D

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::824b796ec2fff7c077a659e9dcb0d79a
https://doi.org/10.1111/j.1464-410x.2012.10945.x

Zobrazit plný text záznamu

A cost-analysis comparison of laparoscopic radical prostatectomy versus open radical prostatectomy: the McMaster Institute of Urology experience

Autor: Leo Winter, Tariq F. Al-Shaiji, Vikram Comondore, Niki Kanaroglou, Paul Whelan, Connie Prowse, Achilleas Thoma, Edward D. Matsumoto, Kevin Piercey, Orovan Wl

Publikováno v: Canadian Urological Association journal = Journal de l'Association des urologues du Canada. 4(4)

Introduction: The objective of this study was to identify and compare the costs of laparoscopic radical prostatectomy (LRP) and radical retropubic prostatectomy (RRP) at our centre. Methods: We conducted a retrospective chart review of our first 70 c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f7c9788d64622a2fdf4795bb32908d7
https://pubmed.ncbi.nlm.nih.gov/20694097

Zobrazit plný text záznamu

High-intensity focused ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: Predictors of disease response

Autor: Shawn Dason, Bobby Shayegan, Jen Hoogenes, Orovan Wl, Christopher B. Allard

Publikováno v: Journal of Clinical Oncology. 34:135-135

135 Background: Some patients with localized radio-recurrent prostate cancer (PCa) may have long-term recurrence-free (RFS) survival with salvage high-intensity focused ultrasound (HIFU). In this study, we describe our previously unreported oncologic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9358067726bf07e01dd0c40b2bae49ff
https://doi.org/10.1200/jco.2016.34.2_suppl.135

Zobrazit plný text záznamu

How to use an article about therapy

Autor: Philipp Dahm, Orovan Wl, Harriette M. Scarpero, Sohail Bajammal, Mohit Bhandari

Publikováno v: The Journal of urology. 180(5)

Most surgical interventions have inherent benefits and associated risks. Before implementing a new therapy we should ascertain the benefits and risks of the therapy and assure ourselves that the resources consumed in the intervention will not be exor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e07d064c619d8bdfcc5c41d090c8f9
https://pubmed.ncbi.nlm.nih.gov/18801503

Zobrazit plný text záznamu

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia

Autor: John Trachtenberg, Ernest W. Ramsey, Mostafa M. Elhilali, Laurence Klotz, Gilles Béland, Jack Barkin, Rex Boake, Richard Casey, Erik Schick, Yves Fradet, Orovan Wl

Publikováno v: Urology. 47(3)

Objectives This study was designed to evaluate the safety and efficacy of the selective α 1 -adrenoceptor blocker terazosin in the treatment of benign prostatic hyperplasia (BPH). Methods Two hundred twenty-four patients aged 50 to 80 years, who had

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41dfdb2f46a8684c5af092ed790ba531
https://pubmed.ncbi.nlm.nih.gov/8633398

Zobrazit plný text záznamu

Two-years biochemical failure-free survival following high intensity focused ultrasound (HIFU) for localized prostate cancer: Prospective single center study of 196 patients

Autor: Orovan Wl, Jehonathan H. Pinthus, Magdy M. Hassouna, Forough Farrokhyar, E. Woods

Publikováno v: Journal of Clinical Oncology. 27:5117-5117

5117 Background: HIFU is an emerging ablative modality for the treatment of localized prostate cancer with limited reports on oncological outcome. We prospectively analyzed our 2-year results. Methods: 253 consecutive patients (age: 64+8) were treate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a8a07fbd5a38f3dfd366e6ade80bfb07
https://doi.org/10.1200/jco.2009.27.15_suppl.5117

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání